C6orf100 Inhibitors
The term C6orf100 Inhibitors designates a class of chemical compounds strategically designed to selectively impede the activity of the C6orf100 protein. C6orf100, denoting Chromosome 6 Open Reading Frame 100, represents a gene that encodes a protein with as yet unresolved functions within cellular processes. This particular class of inhibitors is instrumental in the realm of scientific investigation, serving as specialized tools to unravel the mysteries surrounding the molecular roles and cellular functions governed by C6orf100. As researchers delve into the intricacies of the human genome, proteins like C6orf100 emerge as focal points of interest, prompting the development of inhibitors as a means to interrogate their functions.
The synthesis and refinement of C6orf100 inhibitors demand a thorough understanding of the protein's structural attributes and its involvement in cellular pathways. These inhibitors are meticulously crafted for specificity, aiming to selectively bind to critical regions of C6orf100 and disrupt its normal biochemical activities. By utilizing these inhibitory compounds in experimental settings, scientists can discern the impact of C6orf100 inhibition on cellular processes, contributing to a deeper comprehension of its roles within molecular pathways. The study of C6orf100 inhibitors represents a vital stride in the ongoing exploration of the human proteome, unraveling the functions of less-explored genes and proteins, and providing valuable insights into the intricate orchestration of cellular activities.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Simvastatin inhibits HMG-CoA reductase, affecting prenylation of Rho GTPases, which could indirectly downregulate ARHGAP40 expression linked to Rho GTPase regulation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a selective Rho-associated protein kinase (ROCK) inhibitor. By blocking ROCK activity, it may indirectly affect ARHGAP40 expression, given its role in modulating Rho GTPase signaling pathways. | ||||||
Fluoxetine hydrochloride | 56296-78-7 | sc-201125 sc-201125A sc-201125B sc-201125C | 50 mg 250 mg 1 g 5 g | $75.00 $209.00 $399.00 $849.00 | 14 | |
Secramine A interferes with Cdc42, a member of the Rho GTPase family. By disrupting Cdc42 activity, it may indirectly affect ARHGAP40 expression as part of the intricate Rho GTPase regulatory network. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $132.00 | 19 | |
IWR-1-endo is a Wnt pathway inhibitor that may influence downstream signaling cascades, potentially impacting ARHGAP40 expression linked to Wnt-dependent regulation of Rho GTPase pathways. | ||||||
Thiazovivin | 1226056-71-8 | sc-361380 sc-361380A | 10 mg 25 mg | $278.00 $622.00 | 15 | |
Rhosin is a selective inhibitor of RhoA activation. By inhibiting RhoA, it may modulate ARHGAP40 expression, as RhoA is a key player in the Rho GTPase signaling network that ARHGAP40 is involved in regulating. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $134.00 $502.00 | 7 | |
ML141 is a selective Cdc42 inhibitor. By inhibiting Cdc42, it may indirectly affect ARHGAP40 expression, given the interconnected nature of the Rho GTPase family in cellular signaling pathways. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $92.00 $348.00 | 46 | |
CASIN is a small molecule inhibitor of Cdc42. By blocking Cdc42 activity, it may influence ARHGAP40 expression, given the involvement of Cdc42 in the intricate regulation of Rho GTPase signaling pathways. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $209.00 $872.00 | 12 | |
EHT 1864 is a Rac1 inhibitor. By selectively inhibiting Rac1, it may impact ARHGAP40 expression, as Rac1 is a member of the Rho GTPase family involved in signaling pathways regulated by ARHGAP40. | ||||||